Efforts needed to stop the spread of carbapenem-resistant Acinetobacter baumannii

December 14, 2016

Acinetobacter baumannii is the cause of difficult-to-treat infections in healthcare settings in Europe due to its increasing resistance to antimicrobial agents, in particular the carbapenems. Outbreaks of carbapenem-resistant A. baumannii in healthcare facilities have been reported in Europe and worldwide.

Infections with carbapenem-resistant A. baumannii occur in patients with severe underlying diseases, mainly in intensive care units, and are often related to invasive procedures or indwelling devices. However, such infections are increasingly being reported in patients admitted to conventional medical and surgical wards. A. baumannii is difficult to eradicate once it has become endemic.

Recent ECDC data from the European survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project and from the European Antimicrobial Resistance Surveillance Network (EARS-Net) confirmed that although there is already a high resistance baseline in some countries, there has been an overall increase of carbapenem-resistant A. baumannii in Europe.

These data confirm an already alarming situation that continues to worsen in many EU/EEA countries. While carbapenems traditionally were the antibiotics of choice for treatment of A. baumannii infections, resistance to these drugs has led to increased use of colistin as last-line treatment. Although still rare, resistance to colistin in A. baumannii is also increasingly being reported in Europe.

ECDC's risk assessment highlights the need of increased efforts to face this significant threat to patients and healthcare systems in all EU/EEA countries and outlines options to reduce risks through clinical management, prevention of transmission in hospitals and other healthcare settings, prevention of cross-border transmission, and improvement of preparedness of EU/EEA countries.
-end-
Rapid risk assessment: carbapenem-resistant Acinetobacter baumannii in healthcare settings

Summary of the latest data on antibiotic resistance in the European Union, EARS-Net surveillance data

ECDC Surveillance Atlas of Infectious Diseases

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015

European Antimicrobial Resistance Surveillance Network (EARS-Net)

European Surveillance of Antimicrobial Consumption Network (ESAC-Net)

ECDC Antimicrobial Resistance and Healthcare-associated Infections Programme

European Centre for Disease Prevention and Control (ECDC)

Related Infections Articles from Brightsurf:

Understanding the progress of viral infections
A team of researchers at the Institute for the Genetics of Heart Diseases at M√ľnster University created a viral expression model that can be used to simulate and analyse a large number of viral infections - including the one with SARS-CoV-2.

How viral infections associated with cancer become persistent?
A new study led by Pedro Simas, group leader at Instituto de Medicina Molecular (iMM; Portugal) and Kenneth M.

New drug formulation could treat Candida infections
With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.

A 'shocking' new way to treat infections
New research from the University of Pittsburgh's Swanson School of Engineering introduces a revolutionary treatment for these infections.

Young infants with fever may be more likely to develop infections
Infants with a high fever may be at increased risk for infections, according to research from Penn State College of Medicine.

Hospital infections declining in Canada
There is good news on the infection front: infections acquired by patients in Canadian hospitals are declining, with a 30% reduction between 2009 and 2017, according to new research in CMAJ (Canadian Medical Association Journal).

Helminthic infections may be beneficial against HIV-1
Infection with parasitic helminths can reduce the susceptibility of T-cells to HIV-1 infection, according to a study published Sept.

Waking up sleeping bacteria to fight infections
Researchers in the group of Jan Michiels (VIB-KU Leuven Center for Microbiology) identified a mechanism of how sleepy bacteria wake up.

Typhoid vaccine may protect against other infections
New research by the University of Liverpool and Liverpool School of Tropical Medicine shows that vaccination with weakened strains of Salmonella may also protect against other infections.

New AI can detect urinary tract infections
New AI developed at the University of Surrey could identify and help reduce one of the top causes of hospitalisation for people living with dementia: urinary tract infections (UTI).

Read More: Infections News and Infections Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.